Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care
Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024
Rockwell Medical Added to Russell Microcap Index
Rockwell Medical Announces Fourth Quarter and Full-Year 2022 Financial and Operational Results
Rockwell Medical to Showcase its Hemodialysis Concentrates Portfolio at DialysisTechConneXion40
Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from Baxter
WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that Heather Hunter has joined the Company as SVP, Chief Corporate Affairs Officer. In this role, Heather will be responsible for the Company’s investor relations, media relations, government affairs, patient advocacy, communications, and branding.
Rockwell Medical, Inc. (Nasdaq: RMTI) has closed the previously announced $15 Million in financing, consisting of $12 Million in a Registered Direct...
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management,...